Lee's Pharmaceutical Holdings Limited (SEHK: 950)
Health Care · Pharmaceuticals · HK
HK$1.14
-3.80% today · -43.6% 1Y
Lee's Pharmaceutical Holdings Limited (SEHK: 950) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $85.62M.
Over the last twelve months the share price has lost 43.6%, trading between 0.99 and 2.70.
Tweenvest scores Lee's Pharmaceutical Holdings Limited across four factors: quality 79/100, value 60/100, growth 30/100, dividend 50/100. Its strongest factor is quality.
950 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $85.62M
- Revenue (TTM)
- $184.49M
- P/E
- 7.30
- EPS
- 0.16
- Dividend yield
- 3.95%
- Beta (5Y)
- 0.57
- 52-week high
- HK$2.70
- 52-week low
- HK$0.99
- Avg volume (3M)
- —
- Shares outstanding
- 588.84M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.